FATE insider transactions
Fate Therapeutics Inc. (FATE) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for FATE
- Officer Tahl Cindy sold $48,084 worth of shares (25,590 units at $1.88), decreasing direct ownership by 4% to 628,155 units (SEC Form 4) (withholding obligation)4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- President and CEO Valamehr Bahram sold $54,482 worth of shares (28,946 units at $1.88), decreasing direct ownership by 4% to 635,762 units (SEC Form 4) to satisfy withholding tax4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- Officer Tahl Cindy exercised 166,664 shares at a strike of $1.25, increasing direct ownership by 34% to 653,745 units (SEC Form 4)4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- Director Epstein Robert S exercised 25,000 shares at a strike of $1.69, increasing direct ownership by 221% to 36,331 units (SEC Form 4)4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- Director Rastetter William H exercised 25,000 shares at a strike of $1.69, increasing direct ownership by 221% to 36,331 units (SEC Form 4)4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- Amendment: SEC Form 4 filed by Director Redmile Group, Llc4/A - FATE THERAPEUTICS INC (0001434316) (Issuer)
- SEC Form 4 filed by Redmile Group, Llc4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- Officer Tahl Cindy was granted 100,000 shares, increasing direct ownership by 26% to 487,081 units (SEC Form 4)4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- Chief Financial Officer Adawi Kamal was granted 25,000 shares, increasing direct ownership by 33% to 100,000 units (SEC Form 4)4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- President and CEO Valamehr Bahram was granted 335,000 shares, increasing direct ownership by 102% to 664,708 units (SEC Form 4)4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- Officer Tahl Cindy sold $11,275 worth of shares (10,589 units at $1.06), decreasing direct ownership by 3% to 387,081 units (SEC Form 4)4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- President and CEO Valamehr Bahram sold $5,557 worth of shares (5,190 units at $1.07), decreasing direct ownership by 2% to 329,708 units (SEC Form 4)4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- Chief Financial Officer Adawi Kamal was granted 75,000 shares (SEC Form 4)4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- SEC Form 3 filed by new insider Adawi Kamal3 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- Officer Tahl Cindy sold $9,573 worth of shares (9,037 units at $1.06), decreasing direct ownership by 2% to 397,670 units (SEC Form 4)4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- President and CEO Valamehr Bahram sold $15,396 worth of shares (14,466 units at $1.06), decreasing direct ownership by 4% to 334,898 units (SEC Form 4)4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- New insider Redco Ii Master Fund, L.P. claimed ownership of 8,977,624 shares (SEC Form 3)3 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- SEC Form 4 filed by Director Lee Michael Stewart4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- SEC Form 4 filed by Director Redmile Group, Llc4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- SEC Form 4 filed by Director Xu Yuan4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- SEC Form 4 filed by Director Mozaffarian Neelufar4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- SEC Form 4 filed by Director Rastetter William H4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- SEC Form 4 filed by Director Mendlein John4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- SEC Form 4 filed by Director Jooss Karin4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- SEC Form 4 filed by Director Epstein Robert S4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- SEC Form 4 filed by Director Abernethy Matt4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- SEC Form 4 filed by Director Agarwal Shefali4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- SEC Form 3 filed by new insider Abernethy Matt3 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- SEC Form 4 filed by President and CEO Valamehr Bahram4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- Officer Tahl Cindy was granted 70,000 shares, increasing direct ownership by 21% to 406,707 units (SEC Form 4)4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- Officer Bressi Jerome Charles was granted 65,000 shares, increasing direct ownership by 24% to 335,203 units (SEC Form 4)4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- Officer Bressi Jerome Charles sold $9,269 worth of shares (5,980 units at $1.55), decreasing direct ownership by 2% to 270,203 units (SEC Form 4)4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- Officer Tahl Cindy sold $8,764 worth of shares (5,654 units at $1.55), decreasing direct ownership by 2% to 336,707 units (SEC Form 4)4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- President and CEO Valamehr Bahram sold $13,406 worth of shares (8,705 units at $1.54), decreasing direct ownership by 2% to 349,364 units (SEC Form 4)4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- Director Redmile Group, Llc sold $573,943 worth of shares (341,633 units at $1.68), bought $668,580 worth of shares (397,964 units at $1.68), disposed of $1,822,692 worth of shares (1,084,936 units at $1.68) and acquired $1,822,692 worth of shares (1,084,936 units at $1.68) (SEC Form 4)4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- Director Redmile Group, Llc converted options into 30,110 shares (SEC Form 4)4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- New insider Bressi Jerome Charles claimed ownership of 276,183 shares (SEC Form 3)3 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- Director Xu Yuan sold $2,678 worth of shares (633 units at $4.23), decreasing direct ownership by 7% to 8,669 units (SEC Form 4)4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- Chief R&D Officer Valamehr Bahram was granted 200,000 shares, increasing direct ownership by 127% to 358,069 units (SEC Form 4)4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- SEC Form 4 filed by Director Mozaffarian Neelufar4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- General Counsel and Secretary Tahl Cindy was granted 200,000 shares, increasing direct ownership by 140% to 342,361 units (SEC Form 4)4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- SEC Form 3 filed by new insider Mozaffarian Neelufar3 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- SEC Form 4 filed by Director Lee Michael Stewart4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- SEC Form 4 filed by Director Redmile Group, Llc4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- SEC Form 4 filed by Director Rastetter William H4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- SEC Form 4 filed by Director Jooss Karin4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- SEC Form 4 filed by Director Coughlin Timothy4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- SEC Form 4 filed by Director Agarwal Shefali4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- SEC Form 4 filed by Director Xu Yuan4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- SEC Form 4 filed by Director Epstein Robert S4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- SEC Form 4 filed by Director Mendlein John4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- SEC Form 4 filed by Redmile Group, Llc4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- SEC Form 4 filed by Wolchko J Scott4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- SEC Form 4 filed by Tahl Cindy4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- SEC Form 4 filed by Dulac Edward J Iii4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- SEC Form 4 filed by Valamehr Bahram4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- Dulac Edward J Iii sold $9,245 worth of shares (1,849 units at $5.00), decreasing direct ownership by 2% to 103,926 units (SEC Form 4)4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- Tahl Cindy sold $47,519 worth of shares (10,874 units at $4.37), decreasing direct ownership by 7% to 142,361 units (SEC Form 4)4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- Valamehr Bahram sold $49,367 worth of shares (11,271 units at $4.38), decreasing direct ownership by 7% to 158,069 units (SEC Form 4)4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
- Wolchko J Scott sold $62,889 worth of shares (14,391 units at $4.37), decreasing direct ownership by 4% to 371,248 units (SEC Form 4)4 - FATE THERAPEUTICS INC (0001434316) (Issuer)